RT Journal Article
SR Electronic
T1 Association between Abnormal Fetal Head Growth and Autism Spectrum Disorder
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.08.09.20170811
DO 10.1101/2020.08.09.20170811
A1 Regev, Ohad
A1 Cohen, Gal
A1 Hadar, Amnon
A1 Schuster, Jenny
A1 Flusser, Hagit
A1 Michaelovski, Analya
A1 Meiri, Gal
A1 Dinstein, Ilan
A1 Hershkovitch, Reli
A1 Menashe, Idan
YR 2020
UL http://medrxiv.org/content/early/2020/08/23/2020.08.09.20170811.abstract
AB Despite evidence for prenatal onset of abnormal head growth in children with autism spectrum disorder (ASD), fetal ultrasound studies in ASD are limited and controversial. We conducted a longitudinal matched case-sibling-control study on fetal ultrasound biometric measures from 174 ASD children, their own typically developed siblings (TDS; n=178) and other population-based typically developed children (TDP; n=176). During second trimester, ASD and TDS fetuses had significantly smaller biparietal diameter (BPD) than TDP fetuses (aORzBPD=0.685, 95%CI=0.527-0.890 and aORzBPD=0.587, 95%CI=0.459-0.751, respectively). Interestingly, sex had a significant effect on head growth with males having larger heads than females within and across groups. Also, males and females with ASD showed different head shapes which were inversely correlated with ASD severity across different gestation periods. Our findings suggest that abnormal fetal head growth is a familial trait of ASD, which is modulated by sex and is associated with the severity of the disorder.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study was partially supported by a grant from the Israeli Science Foundation (527/15).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The study was approved by the Ethics Committee of the Soroka University Medical Center, Beer-Sheva, Israel per the Helsinki declaration (SOR #295-18).All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData about ASD status and characteristics were obtained from the database of the National Autism Research Center of Israel https://www.autismisrael.org/regional-database